Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Provan

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Hematology (Amsterdam, Netherlands)|December 12, 2003
Adult idiopathic thrombocytopenic purpuraAdam J Mead, Adrian C Newland, Drew Provan
Medicina (Kaunas, Lithuania)|April 28, 2023
Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal ViewTomás José González-López, Adrian Newland, Drew Provan
Expert Review of Hematology|February 19, 2024
Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thrombocytopenia managementDrew Provan, Jecko Thachil, María Teresa Álvarez Román
British Journal of Haematology|August 30, 2008
Rituximab in the treatment of autoimmune haematological disordersDrew Provan, Adrian C Newland, Sergio Amadori, et al.
Blood|September 21, 2004
Comparison of rHuEpo plus rHuG-CSF and supportive care: apples to orangesRoberto Stasi, Sergio Amadori, Adrian C Newland, et al.
Leukemia & Lymphoma|July 16, 2005
Infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment for myelodysplastic syndromesRoberto Stasi, Sergio Amadori, Adrian C Newland, et al.
Blood Reviews|May 1, 2026
Supportive strategies in thrombocytopenia: Platelet transfusion and beyondTomás José González-López, David J Kuter, Drew Provan
American Journal of Hematology|February 18, 2011
Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disordersDaan Dierickx, André Delannoy, Khalid Saja, et al.
Blood Reviews|January 13, 2017
The role of splenectomy in autoimmune hematological disorders: Outdated or still worth considering?Judith Sys, Drew Provan, Alexander Schauwvlieghe, et al.
Current Opinion in Hematology|August 27, 2010
Recent progress in understanding the pathogenesis of immune thrombocytopeniaJohn W Semple, Drew Provan, M Bernadette Garvey, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Hematology (Amsterdam, Netherlands)|December 12, 2003
Adult idiopathic thrombocytopenic purpuraAdam J Mead, Adrian C Newland, Drew Provan
Medicina (Kaunas, Lithuania)|April 28, 2023
Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal ViewTomás José González-López, Adrian Newland, Drew Provan
Expert Review of Hematology|February 19, 2024
Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thrombocytopenia managementDrew Provan, Jecko Thachil, María Teresa Álvarez Román
British Journal of Haematology|August 30, 2008
Rituximab in the treatment of autoimmune haematological disordersDrew Provan, Adrian C Newland, Sergio Amadori, et al.
Blood|September 21, 2004
Comparison of rHuEpo plus rHuG-CSF and supportive care: apples to orangesRoberto Stasi, Sergio Amadori, Adrian C Newland, et al.
Leukemia & Lymphoma|July 16, 2005
Infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment for myelodysplastic syndromesRoberto Stasi, Sergio Amadori, Adrian C Newland, et al.
Blood Reviews|May 1, 2026
Supportive strategies in thrombocytopenia: Platelet transfusion and beyondTomás José González-López, David J Kuter, Drew Provan
American Journal of Hematology|February 18, 2011
Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disordersDaan Dierickx, André Delannoy, Khalid Saja, et al.
Blood Reviews|January 13, 2017
The role of splenectomy in autoimmune hematological disorders: Outdated or still worth considering?Judith Sys, Drew Provan, Alexander Schauwvlieghe, et al.
Current Opinion in Hematology|August 27, 2010
Recent progress in understanding the pathogenesis of immune thrombocytopeniaJohn W Semple, Drew Provan, M Bernadette Garvey, et al.
Pageof 9